This segment focuses on the research, development, production, and sale of products designed to treat anorectal conditions, with a primary emphasis on hemorrhoids. Mayinglong's flagship product, Mayinglong Musk Hemorrhoid Ointment, is a key offering in this area. Research efforts are directed towards improving the efficacy and safety of existing formulations, as well as exploring new treatment modalities. The company leverages traditional Chinese medicine principles combined with modern pharmaceutical technologies to create innovative solutions. Clinical trials are conducted to validate the effectiveness of these products, aiming to improve patient outcomes and quality of life. The segment holds a strong market position in China, with potential for further expansion through online sales channels and strategic partnerships.